Pharmacogenetic testing for guiding prescription of biologic medications? Myths vs reality

The escalating cost of biologic medications has private and public plan sponsors concerned. Many are turning to new technologies to stratify patient populations with the aim of reducing the total cost of biologics. Some providers are considering pharmacogenetic tests to guide selection of drug therapy. Others are looking at...

Can I use my ancestry genetic test results to get a Pillcheck report?

Ancestry genetic testing is a great introduction to genetics for many people. Direct-to-consumer ancestry tests can predict how much Neanderthal DNA you’ve inherited or that your eyes are blue rather than brown. These tests are entertaining, affordable and have changed the relationship we have with our DNA. Customers who order...

Cannabis – How can private health benefits plan sponsors and insurers make the right coverage decisions for plan members?

The legalization of cannabis poses a challenge for employers and insurers, as they are expected to cover the cost of medical cannabis as a part of their employee health benefits. A recent Deloitte report indicates that 7% of adult Canadian population are daily cannabis users, of which 29% are...

What is Seasonal Affective Disorder (SAD) and what are my treatment options?

Seasonal Affective Disorder Many people find themselves feeling down during the dark and dreary winter months. For some, the winter blues become serious depression. Seasonal affective disorder (SAD) is a pattern of major depressive episodes, with symptoms typically occurring each year during the fall and winter. Dr. Norman E. Rosenthal...

Cannabis for pain management: is it for everyone?

Among the recreational users, less than 30% of Cannabis is used for specific medical reasons, such as chronic pain management, nausea treatment, or anxiety and sleep. Source: A society in transition, an industry ready to bloom from Deloitte According to Health Canada, there are just under 300,000 registered medical cannabis users...

The SLC6A4 gene and response to antidepressants: Why the evidence still isn’t enough

Growing scientific evidence shows a link between the SLC6A4 gene and response to antidepressants. The SLC6A4 gene is involved in regulating serotonin – the brain chemical that influences everything from sleep to appetite to mood. Some genetic testing companies test SLC6A4 gene variations, promising to predict your response to antidepressants...

The Pillcheck Difference

Choosing the Right PGx Test As pharmacogenetics testing becomes more widely available, it is important to understand that not all tests are the same. Different testing companies provide different recommendations with regards to applying information from PGx tests into clinical practice. It is important to understand what you are getting...